ATE209862T1 - Isolierung von lactoferrin aus milch - Google Patents

Isolierung von lactoferrin aus milch

Info

Publication number
ATE209862T1
ATE209862T1 AT95909735T AT95909735T ATE209862T1 AT E209862 T1 ATE209862 T1 AT E209862T1 AT 95909735 T AT95909735 T AT 95909735T AT 95909735 T AT95909735 T AT 95909735T AT E209862 T1 ATE209862 T1 AT E209862T1
Authority
AT
Austria
Prior art keywords
lactoferrin
milk
isolation
lactoferrins
eluted
Prior art date
Application number
AT95909735T
Other languages
English (en)
Inventor
Jan H Nuijens
Harry H Van Veen
Original Assignee
Pharming Intellectual Pty Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharming Intellectual Pty Bv filed Critical Pharming Intellectual Pty Bv
Application granted granted Critical
Publication of ATE209862T1 publication Critical patent/ATE209862T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/146—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by ion-exchange
    • A23C9/1465—Chromatographic separation of protein or lactose fraction; Adsorption of protein or lactose fraction followed by elution
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/832—Milk; colostrum

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT95909735T 1994-02-16 1995-02-16 Isolierung von lactoferrin aus milch ATE209862T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19832194A 1994-02-16 1994-02-16
PCT/EP1995/000583 WO1995022258A2 (en) 1994-02-16 1995-02-16 Isolation of lactoferrin from milk

Publications (1)

Publication Number Publication Date
ATE209862T1 true ATE209862T1 (de) 2001-12-15

Family

ID=22732892

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95909735T ATE209862T1 (de) 1994-02-16 1995-02-16 Isolierung von lactoferrin aus milch

Country Status (11)

Country Link
US (3) US5861491A (de)
EP (2) EP1142484A2 (de)
JP (1) JPH09509165A (de)
AT (1) ATE209862T1 (de)
AU (1) AU1809895A (de)
CA (1) CA2183459A1 (de)
DE (1) DE69524386D1 (de)
FI (1) FI963197A0 (de)
NO (1) NO963163L (de)
NZ (1) NZ330484A (de)
WO (1) WO1995022258A2 (de)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6268487B1 (en) 1996-05-13 2001-07-31 Genzyme Transgenics Corporation Purification of biologically active peptides from milk
WO1998033509A2 (en) * 1997-02-03 1998-08-06 Pharming Intellectual Property Bv Useful properties of human lactoferrin and variants thereof
EP0989860A4 (de) * 1998-04-13 2000-07-19 New England Medical Center Inc Methoden und zusammensetzungen zur inaktivierung infektioeser agentien unter verwendung von laktoferrin und verwandten molekuelen
US6399570B1 (en) * 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
US6642038B1 (en) 1999-09-14 2003-11-04 Genzyme Glycobiology Research Institute, Inc. GlcNAc phosphotransferase of the lysosomal targeting pathway
US6770468B1 (en) 1999-09-14 2004-08-03 Genzyme Glycobiology Research Institute, Inc. Phosphodiester-α-GlcNAcase of the lysosomal targeting pathway
DE60025026T2 (de) * 1999-11-11 2006-08-03 Am-Pharma B.V. Antimikrobielle Wirkung des ersten kationischen Clusters des menschlichen Lactoferrins
US7060677B1 (en) 1999-11-11 2006-06-13 Am-Pharma B.V. Antimicrobial activity of the first cationic cluster of human lactoferrin
NZ501675A (en) 1999-12-09 2002-12-20 New Zealand Dairy Board Translucent milk drink having a pH of 5.7 to 7.0 and a percentage transmission of at least 5% prepared by a cation exchange process
US6800472B2 (en) * 2001-12-21 2004-10-05 Genzyme Glycobiology Research Institute, Inc. Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosimanidase
US20030124652A1 (en) * 2001-12-21 2003-07-03 Novazyme Pharmaceuticals, Inc. Methods of producing high mannose glycoproteins in complex carbohydrate deficient cells
US6905856B2 (en) * 2001-12-21 2005-06-14 Genzyme Glycobiology Research Institute, Inc. Soluble GlcNAc phosphotransferase
US7368141B2 (en) * 2002-03-07 2008-05-06 Upfront Chromatography A/S Process of isolating lactoferrin
JP4516844B2 (ja) 2002-09-16 2010-08-04 エイジェニックス インコーポレイテッド 創傷の処置におけるラクトフェリン
WO2004052305A2 (en) 2002-12-10 2004-06-24 Agennix Incorporated Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease
WO2004054608A2 (en) * 2002-12-12 2004-07-01 Agennix Incorporated Lactoferrin in the reduction of pain
JP4263932B2 (ja) * 2003-04-01 2009-05-13 雪印乳業株式会社 ラクトフェリンの製造方法
US7034126B2 (en) * 2003-05-14 2006-04-25 Agennix, Inc. Lactoferrin in the treatment of diabetes mellitus
WO2005046571A2 (en) * 2003-06-06 2005-05-26 Agennix Incorporated Lactoferrin as an adjuvant in cancer vaccines
US20040259770A1 (en) * 2003-06-19 2004-12-23 Rush University Medical Center Method for determining leukocyte activation
CA2463301A1 (en) * 2004-04-22 2005-10-22 Atanas Iliev Lalev Method for detecting protein interactions - affinity purification with switching the ligand
US7893041B2 (en) * 2003-12-05 2011-02-22 Children's Hospital Medical Center Oligosaccharide compositions and use thereof in the treatment of infection
JPWO2005075500A1 (ja) * 2004-02-03 2008-01-10 学校法人 久留米大学 陽イオン性タンパク質の分離精製方法
WO2005085287A1 (en) * 2004-03-03 2005-09-15 En-N-Tech, Inc. Treatments for contaminant reduction in lactoferrin preparations and lactoferrin-containing compositions
WO2006047744A2 (en) * 2004-10-26 2006-05-04 Agennix Incorporated Compositions of lactoferrin related peptides and uses thereof
US20090306350A1 (en) * 2005-05-13 2009-12-10 Crea Biopharma Inc. New purification method of lactoferrin
FR2901796A1 (fr) * 2006-05-31 2007-12-07 Lab Francais Du Fractionnement Procede d'extraction d'une ou de plusieurs proteines presentes dans du lait
ITRM20060434A1 (it) * 2006-08-07 2008-02-08 Pietro Raimondi Prodotto da somministrare all organismo umano per isuoi effetti protettivi e curativi a base di latte di bufala autorricchito di lattoferrina oppure di lattoferrina tal quale ottenuto attraverso processi separativi di membrana
NZ555163A (en) 2007-05-14 2010-05-28 Fonterra Co Operative Group Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
AU2014201943B2 (en) * 2007-07-10 2016-07-28 Glanbia Nutritionals Method for removing endotoxin from proteins
US7919589B2 (en) * 2007-07-10 2011-04-05 Glanbia Nutritionals (Ireland), Ltd. Method for removing endotoxin from proteins
WO2009033011A1 (en) 2007-09-07 2009-03-12 Children's Hospital Medical Center Use of secretor, lewis and sialyl antigen levels as predictors for disease
EP2077273B1 (de) * 2007-12-31 2011-09-14 Animal Technology Institute Taiwan Verfahren zur Trennung von Casein aus löslichen Proteinen in einer Zusammensetzung
CN101672835B (zh) * 2008-09-09 2012-05-30 光明乳业股份有限公司 一种测定乳制品中乳铁蛋白的方法
FR2940655B1 (fr) 2008-12-31 2011-02-18 Lfb Biotechnologies Peptides isoles de facteur vii de lapin.
PL2391225T3 (pl) * 2009-01-28 2020-11-16 Jean-Paul Perraudin Sposób wytwarzania laktoferyny
EP2451462B1 (de) 2009-07-06 2017-09-06 Children's Hospital Medical Center Entzündungshemmung mit milch-oligosacchariden
AU2011340176A1 (en) * 2010-12-09 2013-06-06 Nestec S.A. Quantitation of lactoferrin in infant formulas by electrophoresis using IR fluorescence imaging
US20120171231A1 (en) 2010-12-29 2012-07-05 Anja Wittke Use of nutritional compositions including lactoferrin in stimulating immune cells
BR112013015458A2 (pt) 2010-12-29 2016-08-09 Mjn Us Holdings Llc uso de composições nutricionais lactoferrina no suporte de resistência a doença e condições
US8968722B2 (en) 2010-12-29 2015-03-03 Mead Johnson Nutrition Company Milk-based nutritional compositions containing lactoferrin and uses thereof
US8648036B2 (en) 2010-12-29 2014-02-11 Mead Johnson Nutrition Company Use of nutritional compositions including lactoferrin and one or more prebiotics in inhibiting adhesion of pathogens in the gastrointestinal tract
PE20141192A1 (es) 2010-12-29 2014-10-01 Mjn Us Holdings Llc Metodo para la inhibicion de patogenos usando una composicion nutricional
US20120171328A1 (en) 2011-01-05 2012-07-05 Dattatreya Banavara Composition comprising heat labile milk proteins and process for preparing same
US9351978B2 (en) 2012-02-29 2016-05-31 Mead Johnson Nutrition Company Neurogenesis screening method and uses thereof
WO2013138991A1 (en) * 2012-03-20 2013-09-26 Nestec S.A. Lactoferrin supplementation and diarrhea
AU2013204858B2 (en) * 2012-10-08 2015-06-25 Saputo Dairy Australia Pty Limited Improved process for purifying milk proteins and products thereof
AU2013204850B2 (en) * 2012-10-08 2015-06-25 Murray Goulburn Co-Operative Co. Limited Improved process for purifying milk proteins and products thereof
US10626460B2 (en) 2013-02-21 2020-04-21 Children's Hospital Medical Center Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease
US20140255365A1 (en) 2013-03-11 2014-09-11 Mead Johnson Nutrition Company Oral Electrolyte Solution Containing Lactoferrin and Uses Thereof
US20140271978A1 (en) 2013-03-15 2014-09-18 Mead Johnson Nutrition Company Low-buffer nutritional compositions and uses thereof
US9458225B2 (en) 2013-06-26 2016-10-04 United Arab Emirates University Method for purifying lactoferrin
US9226914B2 (en) 2013-07-16 2016-01-05 Mead Johnson Nutrition Company Methods for promoting neuronal development and/or health
US9241923B2 (en) 2013-07-16 2016-01-26 Mead Johnson Nutrition Company Methods for promoting neuronal development and/or health
US9661868B2 (en) * 2013-07-16 2017-05-30 Mead Johnson Nutrition Company Expanded bed adsorption methods for isolation of basic milk proteins including lactoferrin
US10709770B2 (en) 2013-07-31 2020-07-14 Mead Johnson Nutrition Company Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
US9609888B2 (en) 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
WO2015050744A2 (en) 2013-10-03 2015-04-09 Mjn U.S. Holdings Llc Neurogenesis screening method and uses thereof
CZ305371B6 (cs) 2013-11-15 2015-08-19 Univerzita PalackĂ©ho Způsob separace syrovátkových proteinů z mléčného média a zařízení k provádění tohoto způsobu
CN103709246B (zh) * 2013-11-25 2015-09-02 北京济福霖生物技术有限公司 一种乳铁蛋白及乳过氧化物酶的纯化方法
US20150157048A1 (en) 2013-12-11 2015-06-11 Mead Johnson Nutrition Company Nutritional compositions containing stearidonic acid and uses thereof
US20150164833A1 (en) 2013-12-17 2015-06-18 Mead Johnson Nutrition Company Nutritional composition containing a neurologic component of ursolic acid and uses thereof
WO2015094532A1 (en) 2013-12-17 2015-06-25 Mjn U.S. Holdings Llc Nutritional composition containing a neurologic component of kaempferol and/or fisetin
US10639334B2 (en) 2014-01-07 2020-05-05 Mead Johnson Nutrition Company Pediatric nutritional composition with milk peptides for healthy growth and development
US10028519B2 (en) 2014-03-05 2018-07-24 Mead Johnson Nutrition Company Nutritional compositions containing ceramide and uses thereof
US20150290261A1 (en) 2014-04-10 2015-10-15 Mead Johnson Nutrition Company Methods of use for probiotics and prebiotics
US20150305359A1 (en) 2014-04-24 2015-10-29 Mead Johnson Nutrition Company Nutritional compositions directed to subjects having cow's milk protein allergies
US20150305385A1 (en) 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
US20160015068A1 (en) 2014-07-16 2016-01-21 Mead Johnson Nutrition Company Nutritional formulas containing oil blends and uses thereof
US20160029682A1 (en) 2014-08-01 2016-02-04 Mead Johnson Nutrition Company Hydrolyzed lactose-containing nutritional compositions and uses thereof
US20160095339A1 (en) 2014-10-01 2016-04-07 Mead Johnson Nutrition Company Nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile
EP3214951A1 (de) 2014-11-07 2017-09-13 MJN U.S. Holdings, LLC Nahrungsmittelzusammensetzungen mit einem präbiotikum und lactoferrin sowie verwendungen davon
WO2016176484A1 (en) 2015-04-28 2016-11-03 Children's Hospital Medical Center Use of oligosaccharide compositions to enhance weight gain
US10525016B2 (en) 2015-06-03 2020-01-07 Mead Johnson Nutrition Company Nutritional compositions containing an elevated level of inositol and uses thereof
US10582714B2 (en) 2015-07-10 2020-03-10 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
US10617701B2 (en) 2015-07-10 2020-04-14 Mead Johnson Nutrition Company Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
US20170006897A1 (en) 2015-07-10 2017-01-12 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
US20170020950A1 (en) 2015-07-23 2017-01-26 Mead Johnson Nutrition Company Methods for modulating kinases
US9730969B2 (en) 2015-11-06 2017-08-15 Mead Johnson Nutrition Company Nutritional compositions for promoting gut barrier function and ameliorating visceral pain
US10034937B2 (en) 2015-12-04 2018-07-31 Mead Johnson Nutrition Company Synergistic nutritional compositions and uses thereof
WO2017158202A1 (en) * 2016-03-18 2017-09-21 Genclis Molecular origin of allergy
US20180064739A1 (en) 2016-09-06 2018-03-08 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
US20180103675A1 (en) 2016-10-14 2018-04-19 Mead Johnson Nutrition Company Personalized pediatric nutrition products comprising human milk oligosaccharides
US20180133287A1 (en) 2016-11-14 2018-05-17 Mead Johnson Nutrition Company Nutritional compositions providing dietary management of colic
US20180153951A1 (en) 2016-12-05 2018-06-07 Mead Johnson Nutrition Company Methods for Inducing Adipocyte Browning, Improving Metabolic Flexibility, and Reducing Detrimental White Adipocyte Tissue Deposition and Dysfunction
US20180161292A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US10980269B2 (en) 2016-12-12 2021-04-20 Mead Johnson Nutrition Company Protein hydrolysates and methods of making same
US20180160714A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180168215A1 (en) 2016-12-21 2018-06-21 Mead Johnson Nutrition Company Nutritional compositions containing inositol and uses thereof
US20180333426A1 (en) 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
US20180332881A1 (en) 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Preterm infant formula containing butyrate and uses thereof
US20190208807A1 (en) 2018-01-05 2019-07-11 Mead Johnson Nutrition Company Nutritional compositions containing milk-derived peptides and uses thereof
GB2573538B (en) 2018-05-09 2023-01-04 Mjn Us Holdings Llc Pediatric nutritional compositions and methods for infants delivered by C-section
AU2019374409B2 (en) 2018-11-06 2024-07-11 Arhel Projektiranje In Inzeniring D.O.O. Method for manufacturing highly purified lactoferrin and lactoperoxidase from milk, colostrum and acid or sweet whey
JP7370224B2 (ja) * 2019-11-08 2023-10-27 ライオン株式会社 ラクトフェリン含有腸溶製剤
FR3115037A1 (fr) * 2020-10-12 2022-04-15 Compagnie Laitiere Europeenne Procédé de purification de fraction de protéines cationiques et fraction ainsi obtenue
CN114414687A (zh) * 2022-01-13 2022-04-29 北京美正生物科技有限公司 一种乳铁蛋白提取用结合缓冲液及其制备方法和应用、牛乳铁蛋白的检测方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2505615A1 (fr) * 1981-05-15 1982-11-19 Elf Aquitaine Procede d'extraction de lactoferrine et d'immunoglobulines du lait
JPS61145200A (ja) * 1984-12-19 1986-07-02 Snow Brand Milk Prod Co Ltd ウシラクトフェリンの分離精製法
IE61701B1 (en) * 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
JPH0725800B2 (ja) * 1987-04-10 1995-03-22 雪印乳業株式会社 硫酸エステル化物を用いて乳からラクトフエリンを分離、精製する方法
US4977137B1 (en) * 1987-06-03 1994-06-28 Baylor College Medicine Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract
SE458818B (sv) * 1987-11-27 1989-05-16 Svenska Mejeriernas Riksforeni Foerfarande foer utvinning av rena fraktioner av laktoperoxidas och laktoferrin ur mjoelkserum
NZ230031A (en) * 1988-07-27 1991-10-25 Snow Brand Milk Products Co Ltd Separation of proteins (e.g. lactoferrin) using affinity gel carrier in a rotary column
US5169936A (en) * 1989-04-14 1992-12-08 Biogen, Inc. Protein purification on immobilized metal affinity resins effected by elution using a weak ligand
CA2351200A1 (en) * 1989-12-01 1991-06-13 Gene Pharming Europe Bv Production of recombinant polypeptides by bovine species and transgenic methods
US5240909B1 (en) * 1990-03-14 1998-01-20 Dietrich Nitsche Use of lactoferrin for treatment of toxic effects of endotoxins
WO1993002098A1 (en) * 1991-07-25 1993-02-04 Commonwealth Scientific And Industrial Research Organisation Isolation of charged particles from fluids
DK0620709T3 (da) * 1992-01-15 1995-12-04 Campina Melkunie Bv Fremgangsmåde til isolering af lactoferrin og lactoperoxidase fra mælk og mælkeprodukter
JPH05202098A (ja) * 1992-01-29 1993-08-10 Snow Brand Milk Prod Co Ltd 乳質原料から生理活性物質の製造法
AU2436095A (en) * 1994-05-05 1995-11-29 Ferrodynamics, Inc. Cloning, expression, and uses of human lactoferrin

Also Published As

Publication number Publication date
NZ330484A (en) 1999-11-29
DE69524386D1 (de) 2002-01-17
EP0744901B1 (de) 2001-12-05
US5849885A (en) 1998-12-15
WO1995022258A2 (en) 1995-08-24
JPH09509165A (ja) 1997-09-16
EP0744901A1 (de) 1996-12-04
AU1809895A (en) 1995-09-04
FI963197A (fi) 1996-08-15
NO963163L (no) 1996-09-16
NO963163D0 (no) 1996-07-29
WO1995022258A3 (en) 1995-11-16
US5919913A (en) 1999-07-06
US5861491A (en) 1999-01-19
EP1142484A2 (de) 2001-10-10
FI963197A0 (fi) 1996-08-15
CA2183459A1 (en) 1995-08-24
MX9603369A (es) 1997-12-31

Similar Documents

Publication Publication Date Title
ATE209862T1 (de) Isolierung von lactoferrin aus milch
AU4922785A (en) Method for separating bovine lactoferrin from cow's milk and purifying same
BG104149A (en) Interleukin-18-binding proteins, methods for their preparation and administration
NZ245789A (en) Separation of lactoperoxidase, `secretory component' and/or lactoferrin from milk
ZA932015B (en) Protein purification
AU1723888A (en) Whey protein fractions
AU3068289A (en) Chromatographic separation of plasma proteins
HUP9904052A3 (en) Monoclonal antibodies againts the extracellular domain of human vegf-receptor protein (kdr)
AU2001242749A1 (en) Peptide derivative
EP0379549A4 (en) Endotoxin binding protein and uses thereof
AU571552B2 (en) Protein concentrates from animal blood
AU3186397A (en) Prion protein binding proteins and uses thereof
EP0716591A4 (de) Verfahren und Präparat zum Binden von TAU und MAP2c Proteinen
EP0239311A3 (de) Wechselseitige Trennung von Proteinen
AU634280B2 (en) Anticoagulant peptides
DK62887A (da) Apparat til sortering med indbyggede fordelings- og udskilningsindretninger
ZA928833B (en) Separation of phytate and manganese from plant protein and dietary fiber using alumina.
SG83647A1 (en) Mouth-care products
EP1017286A4 (de) Aufeinanderfolgende trennung von molkeneiweiss' sowie formulierungen derselben
ZA949789B (en) Process for making undenatured whey protein concentrate
AU5490390A (en) Fatty spread containing native whey protein
IL106591A0 (en) An interferon alpha/beta binding protein,its preparation and pharmaceutical compositions containing it
IL95697A0 (en) Cdna sequence for porcine lactoferrin protein
ATE158591T1 (de) Verfahren zur isolierung von proteinen aus milch und verfahren zur behandlung von milch
EP0674003A3 (de) Proteine die menschliche CNS Rezeptoren modulieren.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties